News from mallinckrodt pharmaceuticals A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 18, 2019, 06:45 ET Mallinckrodt Reports Top-Line Results from Proof-of-Concept Study of Nitric Oxide Gas in Ex-Vivo System of Human Lung Transplants

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced top-line results from its company-sponsored,...


Apr 11, 2019, 06:45 ET Mallinckrodt and Washington University St. Louis Select First Collaborative Research Endeavor

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it has selected the first collaborative research...


Mar 15, 2019, 06:55 ET Mallinckrodt's Hobart, N.Y. and St. Louis, Mo. Sites Recognized as 2019 Manufacturing Leadership Award Winners

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading specialty pharmaceutical company, announced today that sites owned and operated by subsidiaries...


Feb 25, 2019, 06:55 ET Mallinckrodt Announces Extracorporeal Photopheresis Research Collaboration Agreement With Transimmune AG

Mallinckrodt Pharmaceuticals (NYSE:MNK), a leading global specialty pharmaceutical company, today announced it has entered into a research...


Feb 20, 2019, 06:55 ET Mallinckrodt Announces Interim Analysis Results for Therakos® Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease

Mallinckrodt Pharmaceuticals (NYSE:MNK), a leading global specialty pharmaceutical company, today announced interim analysis results of its...


Feb 12, 2019, 06:55 ET Mallinckrodt To Present At Barclays Global Healthcare Conference

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Tuesday, March 12, 2019, at Barclays...


Dec 17, 2018, 06:30 ET Mallinckrodt To Present At 37th Annual J.P. Morgan Healthcare Conference

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Monday, Jan. 7, 2019, at the 37th Annual ...


Nov 08, 2018, 06:45 ET Mallinckrodt Earns International Standard ISO 13485:2016 and Medical Device Single Audit Program (MDSAP) Certifications for INOmax® DSIR® Plus Nitric Oxide Delivery Systems

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it has received the International...


Oct 16, 2018, 06:45 ET Mallinckrodt To Present At Jefferies London Healthcare Conference

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Wednesday, Nov. 14, 2018, at the...


Sep 04, 2018, 06:45 ET Mallinckrodt To Present At Cantor Global Healthcare Conference

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Tuesday, Oct. 2, 2018, at the Cantor...


Jun 22, 2018, 06:30 ET Mallinckrodt plc To Report Earnings Results For Second Quarter Of Fiscal 2018

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, announced today that it will report fiscal 2018 second...


Jun 18, 2018, 06:30 ET Mallinckrodt Reports Interim Findings Of H.P. Acthar® Gel (Repository Corticotropin Injection) Studies

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, recently reported preliminary interim data from ongoing H.P. Acthar® ...


May 14, 2018, 04:45 ET Mallinckrodt To Present At Goldman Sachs 39th Annual Global Healthcare Conference

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Tuesday, June 12, 2018, at the Goldman...


Apr 09, 2018, 06:15 ET Mallinckrodt To Present At Deutsche Bank's 43rd Annual Healthcare Conference

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Wednesday, May 9, 2018, at Deutsche...


Feb 21, 2018, 06:30 ET Mallinckrodt Earns Somerset County Planning Board Land Development Honor

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, announced today its new Specialty Brands office site in...


Feb 15, 2018, 04:50 ET Mallinckrodt To Present At Barclays Global Healthcare Conference

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Wednesday, March 14, 2018, at the...


Feb 06, 2018, 04:45 ET Mallinckrodt To Present At Raymond James 39th Annual Institutional Investors Conference

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Monday, March 5, 2018, at the Raymond...


Dec 08, 2017, 05:55 ET Mallinckrodt To Present At 36th Annual J.P. Morgan Healthcare Conference

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Monday, Jan. 8, 2018, at the 36th Annual ...


Nov 14, 2017, 06:45 ET Mallinckrodt To Present At The BMO Prescriptions for Success Healthcare Conference

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Thursday, Dec. 14, 2017, at the BMO...


Oct 16, 2017, 13:15 ET Mallinckrodt Opens Specialty Brands Office In New Jersey, Announces $100,000 Donation To Princeton University Program For High Achieving, Low-Income High School Students

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, today joined U.S. Rep. Leonard Lance, R-N.J., to mark...


Sep 20, 2017, 06:00 ET Mallinckrodt Announces Election Of David Norton To Its Board Of Directors

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, announced today the election of David Norton to the...


Aug 15, 2017, 07:45 ET Mallinckrodt To Present At Morgan Stanley 15th Annual Global Healthcare Conference

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Tuesday, Sept. 12, 2017, at the Morgan...


Aug 07, 2017, 16:45 ET Mallinckrodt To Present At Wells Fargo Securities 2017 Healthcare Conference

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Thursday, Sept. 7, 2017, at the Wells...


Aug 01, 2017, 07:45 ET Mallinckrodt Enrolls First Patient In Phase 4 Registry Of INOMAX® (Nitric Oxide) Gas For Inhalation For Pulmonary Hypertension In Neonates

Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, today confirmed inclusion of the first patient in the...


Jul 18, 2017, 07:00 ET U.S. FDA Designates Mallinckrodt's StrataGraft® as Regenerative Medicine Advanced Therapy

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced that StrataGraft® regenerative skin tissue is among...